Glaxo Relents, Grants Mylan Paxil License
Mylan Inc. has settled GlaxoSmithKline Plc's infringement suit over Glaxo's blockbuster antidepressant Paxil CR, gaining the right to produce and market all three strengths of its generic version of the drug,...To view the full article, register now.
Already a subscriber? Click here to view full article